CIONIC is a technology company.
CIONIC has raised $13.0M across 1 funding round.
CIONIC has raised $13.0M in total across 1 funding round.
CIONIC is a neurotech startup developing bionic clothing, specifically the FDA-cleared Cionic Neural Sleeve, a wearable leg sleeve that uses AI-powered sensors, real-time analysis, and electrical stimulation to improve mobility for people with neurological conditions like multiple sclerosis, strokes, and spinal cord injuries.[1][3][5] The device detects movement intentions via MultiStim technology, activates functional muscles, relaxes spasms, and adapts stimulation patterns to support walking, daily activities, and long-term muscle retraining, serving patients seeking greater independence.[3][5] With $25M in total funding, including a recent round, CIONIC demonstrates strong growth momentum, having shipped initial units to early adopters and released software updates with exercise regimens and progress reports.[1][3]
CIONIC emerged from a mission to create a platform for human augmentation, transcending physical limitations through wearable tech that integrates hardware, software, and algorithms for personalized mobility enhancement.[1][2][3] While specific founders are not detailed in available sources, the company operates as a small, diverse team in Scotts Valley, California, with expertise spanning mechanical engineering, firmware, Android development, and repair tech, indicating a technical origin likely rooted in biomedical engineering and neurotech research.[2][4] Pivotal early traction includes FDA clearance for the Neural Sleeve, initial shipments to adopters, and recent software expansions addressing daily living challenges, backed by years of research yielding proven results across 20+ conditions.[1][3][5]
CIONIC rides the wave of neurotech and human augmentation, merging AI, wearables, and functional electrical stimulation (FES) to address the growing demand for non-invasive mobility solutions amid aging populations and rising neurological disorders.[1][3][5] Timing is ideal with FDA clearance accelerating adoption, as market forces like advancements in low-power Bluetooth, real-time algorithms, and personalized medicine favor scalable, adaptive devices over invasive implants.[2][4][5] By open-sourcing APIs and targeting 20+ conditions, CIONIC influences the ecosystem, empowering clinicians and researchers to expand applications, potentially reshaping assistive tech from reactive aids to proactive retraining platforms.[3]
CIONIC is poised to scale with Neural Sleeve 2 shipments, software iterations adding ADL exercises, and potential expansions into broader human performance augmentation beyond disabilities.[1][3][5] Trends like AI-driven personalization and regulated wearable tech will propel growth, especially as reimbursement models evolve for neurotech. Their influence may evolve from niche mobility aid to a foundational platform, amplifying independence in a world of physical limits—just as their bionic clothing empowers users to move fearlessly today.[1][5]
CIONIC has raised $13.0M in total across 1 funding round.
CIONIC's investors include BlueRun Ventures, IVP, Khosla Ventures, Maven Ventures, Resolute Ventures, Social Capital, Telescope Partners, Noam Bardin, Ran Makavy.
CIONIC has raised $13.0M across 1 funding round. Most recently, it raised $13.0M Series A in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2022 | $13.0M Series A | BlueRun Ventures, IVP, Khosla Ventures, Maven Ventures, Resolute Ventures, Social Capital, Telescope Partners, Noam Bardin, Ran Makavy |